PHAXIAM Therapeutics S.A. Adjustments For Interest Expense
PHAXIAM Therapeutics S.A. reported Adjustments For Interest Expense of EUR 242.00 thousand for the 6-month period ending 2022-06-30, per its 6-K filed 2022-09-12.
Discontinued › Expense Statement › Interest Expense
ifrs-full:AdjustmentsForInterestExpense · last filed 2022-09-12
| Period end | Adjustments For Interest Expense 6 month | Adjustments For Interest Expense 12 month |
|---|---|---|
| 2022-06-30 | 242.00K EUR 6-K · filed 2022-09-12 | |
| 2021-12-31 | 2.07M EUR 20-F · filed 2022-04-27 | |
| 2021-06-30 | 1.18M EUR 6-K · filed 2022-09-12 | |
| 2020-12-31 | 2.15M EUR 20-F · filed 2022-04-27 | |
| 2020-06-30 | 228.00K EUR 6-K · filed 2021-09-20 | |
| 2019-12-31 | 484.00K EUR 20-F · filed 2022-04-27 | |
| 2019-06-30 | 279.00K EUR 6-K · filed 2020-09-21 | |
| 2018-12-31 | 4.00K EUR 20-F · filed 2021-03-08 | |
| 2018-06-30 | 5.00K EUR 6-K · filed 2019-09-26 | |
| 2017-12-31 | 23.00K EUR 20-F · filed 2020-03-18 | |
| 2016-12-31 | 13.00K EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | 30.00K EUR 20-F/A · filed 2018-05-23 |